Anna C Pavlick Selected Research

Immunoglobulins (Immunoglobulin)

1/2020	Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing.
11/2014	Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna C Pavlick Research Topics

Disease

69	Melanoma (Melanoma, Malignant) 10/2022 - 10/2002
30	Neoplasms (Cancer) 01/2020 - 02/2004
10	Neoplasm Metastasis (Metastasis) 07/2022 - 08/2005
9	Brain Neoplasms (Brain Tumor) 12/2021 - 01/2009
8	Disease Progression 12/2021 - 12/2011
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 10/2002
5	Neutropenia 08/2015 - 10/2002
4	Thrombocytopenia (Thrombopenia) 01/2013 - 10/2002
3	Colitis 12/2021 - 08/2015
3	Fatigue 01/2018 - 01/2009
3	Nausea 01/2018 - 01/2009
2	Hypophysitis 12/2021 - 11/2016
2	Neurologic Manifestations (Neurological Manifestations) 11/2021 - 08/2018
2	Body Weight (Weight, Body) 08/2018 - 05/2015
2	Exanthema (Rash) 01/2018 - 01/2009
2	Testicular Neoplasms (Testicular Cancer) 01/2018 - 07/2008
2	Chills 01/2018 - 06/2012
2	Headache (Headaches) 01/2018 - 11/2011
2	Hyponatremia 08/2015 - 01/2013
2	Breast Neoplasms (Breast Cancer) 12/2011 - 02/2004
2	Alopecia (Baldness) 02/2004 - 10/2002
1	COVID-19 01/2021
1	Macular Degeneration (Age-Related Maculopathy) 09/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 04/2020
1	Carcinoma (Carcinomatosis) 04/2020
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 11/2019
1	Pancreatitis 01/2018
1	Hypophosphatemia 01/2016
1	Hyperbilirubinemia 01/2016
1	Pneumonia (Pneumonitis) 08/2015
1	Myalgia 08/2015

Drug/Important Bio-Agent (IBA)

13	IpilimumabIBA 10/2022 - 06/2011
8	NivolumabIBA 10/2022 - 05/2015
8	Immune Checkpoint InhibitorsIBA 01/2021 - 06/2013
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 02/2013
8	Monoclonal AntibodiesIBA 01/2020 - 06/2011
6	VemurafenibIBA 01/2020 - 07/2010
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2008
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2006
5	Dacarbazine (DIC)FDA LinkGeneric 08/2014 - 10/2006
4	VaccinesIBA 12/2020 - 06/2014
4	pembrolizumabIBA 11/2017 - 08/2015
4	MicroRNAs (MicroRNA)IBA 03/2015 - 03/2010
3	InterferonsIBA 01/2019 - 06/2014
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019 - 10/2006
3	CTLA-4 AntigenIBA 01/2018 - 06/2013
3	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 07/2009
3	EnzymesIBA 01/2016 - 08/2005
2	Alanine Transaminase (SGPT)IBA 12/2021 - 11/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020 - 11/2011
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 11/2014
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019 - 02/2012
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 11/2014
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 11/2014
2	glembatumumab vedotinIBA 01/2019 - 11/2014
2	Carboplatin (JM8)FDA LinkGeneric 12/2016 - 10/2002
2	CreatinineIBA 01/2016 - 01/2013
2	Cytotoxins (Cytolysins)IBA 11/2014 - 01/2011
2	Antisense OligonucleotidesIBA 01/2013 - 10/2006
2	oblimersen (G3139)IBA 01/2013 - 10/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2011 - 10/2002
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2011 - 10/2002
2	DNA (Deoxyribonucleic Acid)IBA 12/2010 - 04/2007
1	Histone Deacetylase InhibitorsIBA 10/2022
1	mocetinostatIBA 10/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	Palladium-103IBA 09/2020
1	Toll-Like Receptor AgonistsIBA 04/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2020
1	cemiplimabIBA 01/2020
1	cobimetinibIBA 01/2020
1	Codon (Codons)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Valine (L-Valine)FDA Link 01/2019
1	ontuxizumabIBA 01/2018
1	PX-866IBA 01/2018
1	AntigensIBA 01/2018
1	HLA-A Antigens (HLA-A)IBA 01/2018
1	HLA-B Antigens (HLA-B)IBA 01/2018
1	HLA-C Antigens (HLA-C)IBA 01/2018
1	ProteomeIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Immune Checkpoint ProteinsIBA 07/2017
1	LigandsIBA 04/2017
1	AntibodiesIBA 01/2017
1	Gemcitabine FDA Link 12/2016
1	Phosphotransferases (Kinase)IBA 12/2016
1	adavosertibIBA 12/2016
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2016
1	pevonedistatIBA 01/2016

Therapy/Procedure

31	Therapeutics 10/2022 - 10/2002
17	Immunotherapy 10/2022 - 02/2013
12	Drug Therapy (Chemotherapy) 11/2017 - 10/2002
5	Radiotherapy 12/2021 - 07/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 04/2020
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 06/2014
2	Intravenous Infusions 11/2016 - 10/2006
1	Injections 09/2020
1	Brachytherapy 09/2020
1	Dermatologic Surgical Procedures 04/2017